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Abstract
Background: In the microbial ecosystem, microbes compete for space and nutrients. Consequently, some have
developed the ability to kill or inhibit the growth of other competing microbes by producing antimicrobial
substances. As the ‘producer’ species are generally immune to these substances, their compounds act on the
competing microbial species and give the producer more space and access to nutrients for growth. Many currently
used antibiotics were developed by exploiting this potential of certain microbes.
Findings: Here, the free-living amoeba, Acanthamoeba castellanii, was investigated for its antibacterial activity
against representative Gram positive and Gram negative bacteria, while bacterial isolates were tested for their
anti-amoebic properties. Conditioned medium from A. castellanii showed remarkable bactericidal properties against
methicillin-resistant Staphylococcus aureus (MRSA) exhibiting almost 100% kill rate, but had limited effect against
Acinetobacter sp., Pseudomonas aeruginosa and vancomycin-resistant Enterococcus faecalis (VRE). Similarly, the
conditioned medium of E. coli K1 and Enterobacter sp., exhibited potent anti-Acanthamoebic effects in a concentration-
dependent manner. Conditioned media of Acanthamoeba, E. coli K1 and Enterobacter sp. showed no cytotoxicity
in vitro when tested against human brain microvascular endothelial cells. Active molecule/s in aforementioned amoebic
and two bacterial conditioned media were 5 – 10 kDa, and <5 kDa respectively.
Conclusions: A. castellanii conditioned medium showed potent bactericidal properties against MRSA. The active
molecule(s) are heat- and pronase-resistant, and in the 5 to 10 kDa molecular mass range. Contrary to this, E. coli K1
and Enterobacter sp., conditioned medium showed anti-amoebic effects that are <5 kDa in molecular mass, suggestive
of active metabolites.
Findings
Infectious diseases account for 68% of global child mor-
tality, with the vast majority occurring in developing
countries [1-3]. Novel antimicrobial agents are urgently
needed to counter multi-drug resistant pathogens [4].
Most clinically used antibiotics are either derived from
natural products especially from microbes or semisyn-
thetic derivatives of these molecules [5-7]. In parallel,
there is a need to expand the range of organisms that
can be tapped in our search to discover natural product
antibiotics. Given the importance of small molecules to
microbial ecology, e.g., penicillin, which is produced by
Penicillium as a defence mechanism [8,9], it is likely that
other microbes can also contribute to the discovery of new
antibiotics. Acanthamoeba is one of the most ubiquitous
protists that has been isolated from diverse environments
[10]. In its natural habitat, i.e., soil and water, Acanth-
amoeba feeds on different bacteria and plays an important
role in the regulation of bacterial populations [11]. How-
ever, certain bacteria especially pathogenic bacteria have
developed strategies to escape the killing mechanisms of
Acanthamoeba and instead use the amoeba as a Trojan
horse or reservoir for their own benefit [12,13]. Some bac-
teria protect themselves from preying amoeba by secreting
soluble anti-Acanthamoeba substances in their medium
[14-16] or directly injecting such substances into Acanth-
amoeba through the type III secretory system [15]. These
findings suggest that Acanthamoeba and Bacteria encoun-
ter each other in the environment routinely. But, how
Acanthamoeba survive the onslaught of overwhelming
bacterial population remains incompletely understood.
Thus, it is reasonable to hypothesize that, in addition
to bacteria, Acanthamoeba also possesses antibiotics to
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counter bacterial attack. As Acanthamoeba and bacteria
thwart each other in their natural habitat, the overall aim
of this study was to determine the anti-bacterial activities
of Acanthamoeba and also the anti-Acanthamoebic prop-
erties of selected bacterial strains.
A keratitis isolate of Acanthamoeba castellanii was ob-
tained from the American Type Culture Collection
(50492) and grown axenically in PYG medium [proteose
peptone 0.75% (w/v), yeast extracts 0.75% (w/v) and glu-
cose 1.5% (w/v)] in tissue culture flasks aerobically at 30°C
without shaking [17-19]. A. castellanii conditioned media
(ACM) were prepared by incubating confluent cultures
(~2×106 trophozoites/mL) for 48 h in PYG. Given con-
fluent cultures, amoebae number increased slightly to
~3×106 trophozoites/mL. Next, cell-free medium was col-
lected by centrifugation (1000 × g for 5 min) and filtered
using 0.22 μM pore size filters. In some experiments, the
ACM was treated at 95°C for 10 min to inactivate A.
castellanii extracellular proteases.
Bacterial isolates used in the present study were Acine-
tobacter sp., Aeromonas hydrophila, Enterobacter aero-
genes, Enterobacter sp., Escherichia coli K1, Klebsiella
pneumoniae, Methicillin-resistant Staphylococcus aureus
(MRSA), Pseudomonas aeruginosa, Shigella flexneri, and
Vancomycin-resistant Enterococcus faecalis (VRE). Esche-
richia coli K1 strain RS218 (O18:K1:H7) and MRSA have
been described previously [20,21]. They were isolated
from the cerebrospinal fluid of a meningitis patient [20]
and blood culture of septicemia patient [21], respectively.
Enterobacter sp. was isolated as a contaminant in Acanth-
amoeba culture, and all other bacteria are clinical isolates
obtained from the Aga Khan University Hospital, Karachi
(available upon request). Bacterial conditioned media
(BCM) were prepared by culturing single colonies (grown
on nutrient agar plates) in 100 mL PYG medium and in-
cubating for 24 h at 37°C aerobically, with shaking. These
conditions resulted in growth of all bacterial cultures to
stationary phase of their growth. The bacterial cultures
were centrifuged at 4000 × g at 4°C for 20 min. The super-
natants were collected and filter sterilized using 0.22 μM
pore size membrane filters. In some experiments, BCM
were treated at 95°C for 10 min to inactivate extracellular
enzymes.
Bacterial conditioned media inhibited A. castellanii growth
To determine amoebistatic activity of BCM, A. castellanii
trophozoites (105 amoebae/0.5 mL/well) were incubated
in PYG with different amounts of BCM in 24 well plates
at 30°C for 48 h. After this incubation, amoebae were
counted using a haemocytometer. In controls, A. castella-
nii trophozoites were incubated in PBS (non-nutrient) and
exhibited no growth (Figure 1A), while A. castellanii incu-
bated in PYG (growth medium) exhibited a nine-fold in-
crease in amoebae numbers from the original inoculum
(Figure 1A). Among the different bacterial isolates tested,
Enterobacter sp., and E. coli K1 BCM inhibited Acanth-
amoeba growth (ca. 98% and 97% amoebistatic effects re-
spectively). To determine whether amoebistatic effects of
BCM were due to nutrient-depletion, A. castellanii tro-
phozoites (105 amoebae in 250 μL PYG) were incubated
with 250 μL of PBS in a 1:1 ratio. The results revealed
amoebae growth profiles, in 50% PBS, similar to amoebae
incubated in neat PYG (Figure 1A). Among other bacteria,
BCM of Acinetobacter sp., A. hydrophila, K. pneumoniae
and MRSA also inhibited A. castellanii growth (ca. 40%,
35%, 33% and 38% amoebistatic effects respectively). The
conditioned media showed amoebistatic properties, indicat-
ing the water soluble nature of the bioactive molecule(s).
In order to address the possibility of conversion of
Acanthamoeba trophozoites into cysts after BCM treat-
ment, BCM-treated Acanthamoeba trophozoites were in-
cubated with 0.5% SDS for 10 min, which is known to
selectively lyse trophozoites [22]. Post-SDS treatment,
none of the BCM-treated Acanthamoeba exhibited cyst
presence. To determine the potency of the compound(s)
in the conditioned media of Enterobacter sp., and E. coli
K1, serial dilutions of the BCM were made and tested
against A. castellanii. The results demonstrated that BCM
of Enterobacter sp. exhibited amoebistatic effects in a
concentration-dependent manner (Figure 1B). At 50% di-
lution, Enterobacter sp. BCM exhibited potent amoebi-
static effects (ca. 97%) (Figure 1B), and similarly E. coli K1
BCM exhibited more than 95% amoebistatic effects
(Figure 1B). However, Enterobacter sp. BCM was found to
be more potent in inhibiting A. castellanii even at lower
dilutions, compared with E. coli K1 BCM (Figure 1B).
Enterobacter sp. and E. coli K1 conditioned media
produced A. castellanii death
For amoebicidal activity of BCM, A. castellanii tropho-
zoites (106 amoebae/0.5 mL/well) were incubated in
PYG with different amounts of BCM in 24 well plates at
30°C for 48 h. Following this incubation, amoebae viabil-
ity was determined by adding 0.1% Trypan blue and
number of live (non-stained) and dead (stained) A. cas-
tellanii were enumerated using a hemocytometer. At
50% concentration, E. coli K1 and Enterobacter sp. BCM
did not affect A. castellanii viability (0% and 0.7% re-
spectively), while at 100% concentration, BCM of both
E. coli K1 and Enterobacter sp. exhibited more than 90%
amoebicidal effects (Figure 1C).
Anti-Acanthamoebic compound(s) in Enterobacter sp.
and E. coli K1 conditioned media are pronase-resistant
and <5 kDa in molecular mass
To determine the molecular mass of the active molecule(s),
conditioned media of Enterobacter sp. and E. coli K1
were filtered through 10 kDa and 5 kDa molecular weight
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Figure 1 The conditioned media of Enterobacter sp. and Escherichia coli K1 exhibited amoebistatic and amoebicidal activities. (A) A. castellanii
(105) were incubated with 50% bacterial conditioned media (BCM) and 50% PYG at 30°C for 48 h. For controls, A. castellanii were incubated with PYG
alone, 100% PBS, and 50% PBS plus 50% PYG. After incubation, amoebae were counted using a haemocytometer. The initial inoculum of 105 amoebae
was used as baseline. Note that the incubation in the non-nutritive 100% PBS showed no growth, while incubation in the growth medium resulted in
over 8-fold increase in the number of amoebae compared with the original inoculum. P-values were calculated by comparing results of 100% PYG with
BCM using student’s t-test. (*) indicates p<0.001. (B) Enterobacter sp. and E. coli K1 BCM were diluted using PYG, where 0% dilution represents neat
BCM, while 50% dilution represents BCM and PYG in 1:1 ratio. A. castellanii (105) were incubated in various dilutions of BCM of Enterobacter sp. and
E. coli K1 and incubated at 30°C for 48 h. After incubation, amoebae were counted using a haemocytometer. The initial inoculum of 105 amoebae
increased to over 8-fold in PYG alone (0% dilution). P-values were calculated by comparing results of 0% BCM (i.e., PYG alone) with different concentrations
of BCM. (*), (**) and (***) indicate p-values of <0.05, <0.01 and <0.001, respectively. (C) A. castellanii (106) were incubated with neat (0%) or diluted
(50%) BCM at 30°C for 24 h. After incubation, 0.1% Trypan blue dye was added and amoebae along with the blue coloured amoebae (dead cells) were
counted using a haemocytometer. Note that cells treated with neat BCM produced A. castellanii death. The data are presented as the mean ± standard
error of three independent experiments performed in duplicate.
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cut off Spin-X UF columns (Corning). Both the eluate and
retentate were used in the aforementioned antimicrobial
assays. To determine the chemical nature of active sub-
stance(s), conditioned media were treated with 1 mg per
mL pronase, mixture of broad spectrum proteases, at
37°C for 4 h. Antimicrobial activity of pronase-treated
conditioned media were determined as described above.
Treatment of pronase did not block A. castellanii growth
inhibitory activities of BCM (Figure 2A). To determine
the approximate mass of active molecules, BCM were
filtered through 10 kDa and 5 kDa size exclusion spin
columns. The results revealed that eluate of both 5 kDa
and 10 kDa exhibited A. castellanii growth suppression
activities, suggesting that the active molecule(s) may be
secondary metabolite(s) (Figure 2B).
Enterobacter sp. and E. coli K1 conditioned media are not
cytotoxic to primary human brain microvascular
endothelial cells
Cytotoxicity assays were performed as previously de-
scribed [20]. Briefly, assays were performed in 24 well
plates containing confluent human brain microvascular
endothelial cells (HBMEC) monolayers. The conditioned
media (250 μL) or PYG medium (250 μL) were added in
250 μL RPMI-1640. Plates were incubated at 37°C in a
5% CO2 incubator and monitored for monolayer disrup-
tions over the period of 24 h. After this incubation, the
supernatants were collected from each well, centrifuged
to remove cellular debris and then cytotoxic effects were
determined by estimating the amount of lactate de-
hydrogenase release from HBMEC using a Cytotoxicity
Detection kit (Roche Applied Sciences). The percent
cytotoxicity was calculated as follows: % cytotoxicity =
(sample value – control value) / (total LDH release –
control value) × 100. Control values were determined by
incubating HBMEC monolayers with RPMI 1640 alone
and total LDH release was obtained by completely lysing
the HBMEC using 1% Triton X-100. Cytotoxicity assays
were performed to determine the effects of the Entero-
bacter sp., and E. coli K1 BCM on primary HBMEC.
Neither E. coli K1 BMC nor Enterobacter sp. BCM pro-
duced host cell cytotoxicity (0.3% and 2% host cell death
respectively). As BCM was prepared using PYG, similar
volume of PYG alone (250 μL) were used as controls.
The results revealed that PYG alone exhibited neither
monolayer disruptions nor HBMEC cytotoxicity (ca. 2%).
A. castellanii conditioned media exhibited potent
antibacterial activities against MRSA
To determine the effects of ACM on multiple drug re-
sistant (MDR) bacteria, clinical isolates of Acinetobacter
sp., P. aeruginosa, MRSA and VRE were used. For anti-
bacterial screening, approximately 106 colony forming
units (c.f.u), suspended in 10 μLwere incubated with
190 μL of ACM at 37°C for 18 h. After incubation, cul-
tures were ten-fold serially diluted in PBS and plated on
agar plates. Plates were incubated at 37°C, overnight and
bacterial c.f.u. were enumerated [7]. For controls, bacteria
were incubated in PYG alone and PBS alone. The results
revealed that ACM killed more than 99% MRSA and ex-
hibited 8% bactericidal effects against VRE, but had no
effect against other bacteria tested (Table 1). Heating at
Figure 2 Anti-Acanthamoebic activities of conditioned media of
Enterobacter sp. and E. coli K1 are resistant to pronase
digestion and smaller than 5 kDa in molecular mass. (A) The
conditioned media of Enterobacter sp. and E. coli K1 were prepared
in PYG. The conditioned media were diluted in PYG in a 1:1 ratio
and treated with 1 mg per mL of Pronase at 37°C for 4 h. Next, A.
castellanii cells (105) were incubated with Pronase-treated and
untreated conditioned media at 30°C for 48 h. After incubation, A.
castellanii were counted using a haemocytometer. The initial inoculum
of 105 A. castellanii was used as a baseline, which increased to over
8-fold in PYG alone. Note that Pronase-treatment had no effect on
growth inhibitory effects of conditioned media. (B) Enterobacter sp.
and E. coli K1 conditioned media were filtered through 10 kDa and
5 kDa MWCO Spin-X UF. The eluate and neat conditioned media
(unfiltered) were incubated with A. castellanii cells (105) for 48 h at
30°C. After incubation, A. castellanii were counted using a haemocytometer.
The initial inoculum of 105 A. castellanii was used as a baseline, which
increased to over 8-fold in PYG alone. Note that eluate from 5 kDa
filters exhibited growth inhibitory effects at levels similar to neat
conditioned media. The data are presented as the mean ± standard
error of three independent experiments performed in duplicate.
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95°C for 10 min had no effect on the bactericidal proper-
ties of ACM. All subsequent experiments were performed
using heated-ACM against MRSA. Serial dilutions showed
that aliquots containing 190 μL ACM exhibited 100% bac-
tericidal effects, 180 μL ACM showed 93.3% bactericidal
effects, whereas dilution of 70%: 30% (ACM:PYG) had no
bactericidal activity (Table 1). Antibacterial activity was
observed in the eluate after passing ACM through 10 kDa
but retained by 5 kDA size-exclusion spin columns, indi-
cating that active ingredient(s) are between 5 to 10 kDa in
molecular mass. The treatment with pronase had no effect
on bactericidal activity of ACM (Table 1). Notably, bacter-
ial growth in PYG medium alone is comparable to LB
(data not shown). The ACM had no cytotoxic effects on
HBMECs in cytotoxicity assays (data not shown).
The presence of antimicrobials in microbes is not a
novel concept and they are known to be an ancient
weapon in the defense against the growth of other mi-
crobes. Since the discovery of penicillin produced in na-
ture by mould, Penicillium in 1928 [8], a large number
of microbes have been tested for the isolation of po-
tentially useful antimicrobials, while there has been
renewed interest in finding new antibiotics from unique
sources such as actinomycetes, cyanobacteria and uncul-
turable bacteria, in addition to known sources such as
streptomycetes.
The ability of bacteria to thrive at high population
densities and the predatory role of Acanthamoeba in the
control of bacterial populations in the environment as
well as the ability of the amoeba to act as a “Trojan
horse” of the microbial world suggests that bacteria-
protists are involved in convoluted interactions [11-16].
The precise nature of such complex interactions is not
clear, but it is shown here that both bacteria and amoe-
bae are able to counter-attack each other and the over-
whelming microbial densities by secreting/harboring
antimicrobials. Among four bacteria tested, it is interesting
that ACM exhibited selective and potent activity against
MRSA. Superbugs, such as MRSA have shown the ability
to cause untreatable infections and have become a major
threat in our fight against bacterial infections [23]. The se-
lective and potent nature of ACM against Gram-positive
MRSA and partly against VRE, but not against Gram-
negative P. aeruginosa is interesting. It is possible that P.
aeruginosa and Acanthamoeba are involved in complex
interactions where the bacteria can employ strategies to
defend itself and counter amoebic attack [23]. Future stud-
ies will test ACM against a large panel of diverse bacterial
pathogens to determine broad-spectrum or species-
specific antibacterial properties. The discovery of antibac-
terial compound(s) from Acanthamoeba will open avenues
for future studies in other free living amoebae/protists as a
potential source of antibiotics for the treatment of emer-
ging bacterial pathogens such as MRSA. Because of
increasing trends in antibiotic resistance in different
pathogenic bacteria [2], the present findings are promising
in our efforts to treat infections caused by drug-resistant
bacteria.
Similarly, among various bacterial isolates tested, BCM
of Enterobacter sp. and E. coli K1 exhibited measurable
amoebistatic and amoebicidal properties. Future studies
will address the question of whether these BCM have se-
lective action against Acanthamoeba or have wide scale
activities against different protist pathogens. Interest-
ingly, neither ACM nor BCM were cytotoxic to brain
endothelial cells in vitro, suggestive of the selective ac-
tion of these conditioned media against MRSA and
Acanthamoeba, respectively. Future studies will further
test the specificity and the absence of putative target(s)
in human cells using primary cells of various origins.
Overall, the present findings are promising in our search
to find additional sources of antimicrobials with novel
modes of action to confront this menace. Work is cur-
rently underway to characterize further the antimicrobial
Table 1 Acanthamoeba conditioned medium (ACM) exhibited selective antibacterial properties
Bacteria + Acanthamoeba conditioned medium (ACM) CFU remaininga
(Bacteria + ACM)
Bacterial kill (%)
Methicillin-resistant Staphylococcus aureus (MRSA, 10 μL) + ACM (190 μL) 0 100
Acinetobacter (10 μL) + ACM (190 μL) 1 × 1010 0
Pseudomonas aeruginosa (10 μL) + ACM (190 μL) 6 × 109 0
Vancomycin resistant Enterococcus faecalis (VRE, 10 μL) + ACM (190 μL) 3.75 × 105 8.12 ± 9.8
MRSA (10 μL) + heated ACM (190 μL) 0 100
MRSA (10 μL) + heated ACM (180 μL) + PYG (10 μL) 6.65 × 104 93.3 ± 9.9
MRSA (10 μL) + heated ACM (140 μL) + PYG (50 μL) 1.55 × 107 0
MRSA (10 μL) + heated ACM eluate of 10 kDa spin exclusion column (190 μL) 0 100
MRSA (10 μL) + heated ACM eluatee of 5 kDa spin exclusion column (190 μL) 1.34 × 1010 0
MRSA (10 μL) + heated-pronase-treated ACM (190 μL) 0 100
The data are presented as the mean ± SE of three independent experiments. aAn inoculum of ~106 bacterial c.f.u. was used.
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properties of ACM and BCM and active components,
possibly novel secondary metabolites in the case of
BCM, being resistant to pronase and heat treatment and
less than 5 kDa in molecular mass. As antimicrobial
resistance is on the increase, finding novel non-toxic
antimicrobial compound(s) from a variety of species
prevalent in clinical settings is crucial. It is hoped that
these molecules will eventually be developed into treat-
ments for bacterial and amoebic infections that are in-
creasingly resistant to currently available drugs, however,
this will require intensive research in the next few years.
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